{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T01:43:55Z","timestamp":1790905435950,"version":"4.1.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","onlinecjc.ca","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Cardiology"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.cjca.2019.05.004","type":"journal-article","created":{"date-parts":[[2019,5,10]],"date-time":"2019-05-10T11:29:11Z","timestamp":1557487751000},"page":"1791-1799","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Variable and Limited Predictive Value of the European Society of Cardiology Hypertrophic Cardiomyopathy Sudden-Death Risk Model: A Meta-analysis"],"prefix":"10.1016","volume":"35","author":[{"given":"Jie","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhipeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2469-6228","authenticated-orcid":false,"given":"Yuancheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanwei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yucheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cjca.2019.05.004_bib1","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1161\/01.CIR.92.4.785","article-title":"Prevalence of hypertrophic cardiomyopathy in a general population of young adults echocardiographic analysis of 4111 subjects in the CARDIA study","volume":"92","author":"Maron","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2019.05.004_bib2","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1093\/eurheartj\/ehu284","article-title":"2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC)","volume":"35","author":"Elliott","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2019.05.004_bib3","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.1016\/j.jacc.2011.10.825","volume":"58","author":"Gersh","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2019.05.004_bib4","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1136\/heartjnl-2012-303271","volume":"99","author":"O'Mahony","year":"2013","journal-title":"Heart"},{"key":"10.1016\/j.cjca.2019.05.004_bib5","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/S0735-1097(03)00941-0","volume":"42","author":"Maron","year":"2003","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2019.05.004_bib6","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1093\/eurheartj\/eht439","article-title":"A\u00a0novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM risk-SCD)","volume":"35","author":"O'Mahony","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2019.05.004_bib7","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1161\/CIRCULATIONAHA.117.030437","article-title":"An international external validation study of the 2014 European Society of Cardiology Guideline on sudden cardiac death prevention in hypertrophic cardiomyopathy (evidence from HCM)","volume":"137","author":"O'Mahony","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2019.05.004_bib8","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1161\/CIRCEP.114.002553","article-title":"Validation of the 2014 ESC Guidelines risk prediction model for the primary prevention of sudden cardiac death in hypertrophic cardiomyopathy","volume":"8","author":"Vriesendorp","year":"2015","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.cjca.2019.05.004_bib9","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.amjcard.2015.05.047","article-title":"Independent assessment of the European Society of Cardiology sudden death risk model for hypertrophic cardiomyopathy","volume":"116","author":"Maron","year":"2015","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjca.2019.05.004_bib10","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.jtcvs.2018.03.150","article-title":"Prediction of sudden death risk in obstructive hypertrophic cardiomyopathy: potential for refinement of current criteria","volume":"156","author":"Desai","year":"2018","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.cjca.2019.05.004_bib11","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1136\/heartjnl-2018-313700","article-title":"Effectiveness of the 2014 European Society of Cardiology guideline on sudden cardiac death in hypertrophic cardiomyopathy: a systematic review and meta-analysis","volume":"105","author":"O'Mahony","year":"2019","journal-title":"Heart"},{"key":"10.1016\/j.cjca.2019.05.004_bib12","doi-asserted-by":"crossref","first-page":"i6460","DOI":"10.1136\/bmj.i6460","article-title":"A\u00a0guide to systematic review and meta-analysis of prediction model performance","volume":"356","author":"Debray","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/j.cjca.2019.05.004_bib13","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1093\/aje\/154.9.854","article-title":"Performance of comorbidity scores to control for confounding in epidemiologic studies using claims data","volume":"154","author":"Schneeweiss","year":"2001","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.cjca.2019.05.004_bib14","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1001\/jama.284.7.876","article-title":"Risk stratification and therapeutic decision making in acute coronary syndromes","volume":"284","author":"Ohman","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.cjca.2019.05.004_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001744","article-title":"Critical appraisal and data extraction for systematic reviews of prediction modelling studies: the CHARMS checklist","volume":"11","author":"Moons","year":"2014","journal-title":"PLoS Med"},{"key":"10.1016\/j.cjca.2019.05.004_bib16","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.cjca.2019.05.004_bib17","doi-asserted-by":"crossref","first-page":"6336","DOI":"10.1038\/s41598-017-06533-0","article-title":"Incremental benefit of late gadolinium cardiac magnetic resonance imaging for risk stratification in patients with hypertrophic cardiomyopathy","volume":"7","author":"Doesch","year":"2017","journal-title":"Sci Rep-Uk"},{"key":"10.1016\/j.cjca.2019.05.004_bib18","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1136\/heartjnl-2015-308453","article-title":"Cardiopulmonary exercise test and sudden cardiac death risk in hypertrophic cardiomyopathy","volume":"102","author":"Magr\u00ec","year":"2016","journal-title":"Heart"},{"key":"10.1016\/j.cjca.2019.05.004_bib19","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.amjcard.2017.10.027","article-title":"Comparison of the prognostic usefulness of the European Society of Cardiology and American Heart Association\/American College of Cardiology Foundation risk stratification systems for patients with hypertrophic cardiomyopathy","volume":"121","author":"Leong","year":"2018","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjca.2019.05.004_bib20","doi-asserted-by":"crossref","first-page":"f198","DOI":"10.1093\/europace\/eux251","article-title":"Validation of the HCM Risk-SCD model in patients with hypertrophic cardiomyopathy following alcohol septal ablation","volume":"20","author":"Liebregts","year":"2018","journal-title":"Europace"},{"key":"10.1016\/j.cjca.2019.05.004_bib21","first-page":"1033","article-title":"Predicting value of 2014 European guidelines risk prediction model for sudden cardiac death (HCM Risk-SCD) in Chinese patients with hypertrophic cardiomyopathy","volume":"45","author":"Li","year":"2017","journal-title":"Zhonghua Xin Xue Guan Bing Za Zhi"},{"key":"10.1016\/j.cjca.2019.05.004_bib22","first-page":"404","article-title":"Feasibility of the 2014 European guidelines risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy in Chinese patients","volume":"45","author":"Zhu","year":"2017","journal-title":"Zhonghua Xin Xue Guan Bing Za Zhi"},{"key":"10.1016\/j.cjca.2019.05.004_bib23","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1016\/j.amjcard.2018.08.042","article-title":"Validation of the 2014 European Society of Cardiology sudden cardiac death risk prediction model among various phenotypes in Japanese patients with hypertrophic cardiomyopathy","volume":"122","author":"Nakagawa","year":"2018","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjca.2019.05.004_bib24","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.amjcard.2016.04.021","article-title":"Validation of the 2014 European Society of Cardiology sudden cardiac death risk prediction model in hypertrophic cardiomyopathy in a reference center in South America","volume":"118","author":"Fern\u00e1ndez","year":"2016","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjca.2019.05.004_bib25","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1016\/j.jcmg.2016.02.031","article-title":"Prognostic value of LGE-CMR in HCM: a meta-analysis","volume":"9","author":"Weng","year":"2016","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.cjca.2019.05.004_bib26","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.jacc.2010.05.010","article-title":"Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy","volume":"56","author":"O'Hanlon","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2019.05.004_bib27","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1161\/CIRCULATIONAHA.109.930636","article-title":"Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: preliminary validation in humans","volume":"122","author":"Flett","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2019.05.004_bib28","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.jcmg.2013.01.011","article-title":"T1 mapping for myocardial extracellular volume measurement by CMR: bolus only versus primed infusion technique","volume":"6","author":"White","year":"2013","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.cjca.2019.05.004_bib29","doi-asserted-by":"crossref","first-page":"e3285","DOI":"10.1161\/CIRCIMAGING.115.003285","article-title":"T1 mapping in discrimination of hypertrophic phenotypes: hypertensive heart disease and hypertrophic cardiomyopathy: findings from the International T1 Multicenter Cardiovascular Magnetic Resonance Study","volume":"8","author":"Hinojar","year":"2015","journal-title":"Circ Cardiovasc Imaging"}],"container-title":["Canadian Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X1930337X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X1930337X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:43:04Z","timestamp":1760107384000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0828282X1930337X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":29,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["S0828282X1930337X"],"URL":"https:\/\/doi.org\/10.1016\/j.cjca.2019.05.004","relation":{},"ISSN":["0828-282X"],"issn-type":[{"value":"0828-282X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Variable and Limited Predictive Value of the European Society of Cardiology Hypertrophic Cardiomyopathy Sudden-Death Risk Model: A Meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cjca.2019.05.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}